Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026

What the insiders did No buying or selling

By person

14 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Wendall Wierenga
Director
—
—
—
116,146
$4.65M
+6.3%
Richard Scott Struthers
President & CEO
—
—
—
111,100
$4.44M
−91.3%
Jeff E. Knight
Chief Dev. & Operating Officer
—
—
—
105,289
$4.21M
+100.2%
Dana Pizzuti
Chief Med and Dev Officer
—
—
—
66,837
$2.67M
+120.3%
Coelho Rogerio Vivaldi
Director
—
—
—
0
$0.00
−100.0%
Wendell Wierenga
Director
—
—
—
0
$0.00
−100.0%
Caren Deardorf
Director
—
—
—
0
$0.00
−100.0%
Matthew K Fust
Director
—
—
—
0
$0.00
−100.0%
Weston Nichols
Director
—
—
—
0
$0.00
−100.0%
Camille L Bedrosian
Director
—
—
—
0
$0.00
−100.0%
Stephanie Okey
Director
—
—
—
0
$0.00
−100.0%
Stephen F. Betz
Chief Scientific Officer
—
—
—
0
$0.00
−100.0%
Tobin Schilke
Chief Financial & Infra. Ofcr.
—
—
—
0
$0.00
−100.0%
Isabel Kalofonos
Chief Commercial Officer
—
—
—
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.